HOME >> BIOLOGY >> NEWS
New success in engineering plant oils

UPTON, NY -- Using genetic manipulation to modify the activity of a plant enzyme, researchers at the U.S. Department of Energy's Brookhaven National Laboratory have converted an unsaturated oil in the seeds of a temperate plant to the more saturated kind usually found in tropical plants. The research will be published online by the Proceedings of the National Academy of Sciences (PNAS) the week of March 5, 2007.

While conversion of an unsaturated oil to an oil with increased saturated fatty acid levels may not sound like a boon to those conscious about consuming unsaturated fats, "the development of new plant seed oils has several potential biotechnological applications," said Brookhaven biochemist John Shanklin, lead author on the paper.

For one thing, the new tropical-like oil has properties more like margarine than do temperate oils, but without the trans fatty acids commonly found in margarine products. Furthermore, engineered oils could be used to produce feedstocks for industrial processes in place of those currently obtained from petrochemicals. Shanklin also suggests that the genetic manipulation could work in the reverse to allow scientists to engineer more heart-healthy food oils.

"Scientists have known for a long time that the ratio of saturated to unsaturated fatty acids plays a key role in plants' ability to adapt to different climates, but to change this ratio specifically in seed oils without changing the climate is an interesting challenge," remarked Shanklin. "Our group sought to gain a better understanding of the enzymes and metabolic pathways that produce these oils to find ways to manipulate the accumulation of fats using genetic techniques."

The researchers focused on an enzyme known as KASII that normally elongates fatty acid chains by adding two carbon atoms. The longer 18-carbon chains are more likely to be acted on by enzymes that desaturate the fat. So the scientists hypothesized that if they could
'"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
5-Mar-2007


Page: 1 2 3

Related biology news :

1. First case of successful ovarian tissue transplantation between two, nonidentical sisters
2. Stem cell procedure successfully treats amyloidosis patients
3. CSHL scientists successfully target tumor microenvironment to stop cancer growth
4. Study shows lizard moms dress their children for success
5. ChemGenex reports successful personalized dosing of Quinamed at ASCO
6. Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin
7. XDx to present recent success with AlloMap molecular expression testing
8. Double honor recognises world-class science and spin-out success
9. Delayed breeding is not necessarily costly to lifetime reproductive success
10. Genes found for successful smoking cessation
11. No need to thank dinosaur-killing asteroid for mammalian success

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
(Date:6/23/2020)... ... , ... In its June 22 online post, business and technology news platform ... Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb Crew ... starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to deliver ... analysis methods. The team has added experienced genealogists, each having over a decade ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ROCKY HILL, Conn. (PRWEB) , ... June 25, ... ... systems company formed to advance photodynamic therapy for treating cancer, today announced the ... Buffalo, New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... ... 2020 , ... Regen Suppliers, the one stop shop for ... get the fourth unit free with no limit on the amniotic derived exosomes. ... have been a game changer for regenerative therapies. The products are manufactured at ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... therapies, today announced that it has filed an Investigational New Drug application (IND) ... clinical trial of its lead drug candidate NBTX-001 in patients with panic disorder ...
Breaking Biology Technology:
Cached News: